JP2017520261A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520261A5
JP2017520261A5 JP2017500849A JP2017500849A JP2017520261A5 JP 2017520261 A5 JP2017520261 A5 JP 2017520261A5 JP 2017500849 A JP2017500849 A JP 2017500849A JP 2017500849 A JP2017500849 A JP 2017500849A JP 2017520261 A5 JP2017520261 A5 JP 2017520261A5
Authority
JP
Japan
Prior art keywords
cistron
promoter
heavy
ranibizumab
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017500849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017520261A (ja
JP6748061B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/055189 external-priority patent/WO2016005931A1/en
Publication of JP2017520261A publication Critical patent/JP2017520261A/ja
Publication of JP2017520261A5 publication Critical patent/JP2017520261A5/ja
Application granted granted Critical
Publication of JP6748061B2 publication Critical patent/JP6748061B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017500849A 2014-07-09 2015-07-09 二重シストロン細菌発現システム Active JP6748061B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2245MU2014 2014-07-09
IN2245/MUM/2014 2014-07-09
PCT/IB2015/055189 WO2016005931A1 (en) 2014-07-09 2015-07-09 Dual cistronic bacterial expression system

Publications (3)

Publication Number Publication Date
JP2017520261A JP2017520261A (ja) 2017-07-27
JP2017520261A5 true JP2017520261A5 (enExample) 2018-08-09
JP6748061B2 JP6748061B2 (ja) 2020-08-26

Family

ID=53773474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500849A Active JP6748061B2 (ja) 2014-07-09 2015-07-09 二重シストロン細菌発現システム

Country Status (20)

Country Link
US (2) US10329571B2 (enExample)
EP (1) EP3167065B1 (enExample)
JP (1) JP6748061B2 (enExample)
CN (1) CN106661588B (enExample)
AU (1) AU2015287296A1 (enExample)
BR (1) BR112017000389A2 (enExample)
CA (1) CA2954594A1 (enExample)
CY (1) CY1123303T1 (enExample)
DK (1) DK3167065T3 (enExample)
ES (1) ES2808906T3 (enExample)
HR (1) HRP20200996T1 (enExample)
HU (1) HUE050300T2 (enExample)
LT (1) LT3167065T (enExample)
MX (1) MX378585B (enExample)
PH (1) PH12017500047A1 (enExample)
PL (1) PL3167065T3 (enExample)
PT (1) PT3167065T (enExample)
RU (1) RU2732148C2 (enExample)
SI (1) SI3167065T1 (enExample)
WO (1) WO2016005931A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6435770B2 (ja) * 2014-01-21 2018-12-12 東ソー株式会社 シグナルペプチドをコードするポリヌクレオチドおよびそれを用いたタンパク質の製造方法
WO2017021819A1 (en) * 2015-07-31 2017-02-09 Dr. Reddy’S Laboratories Limited Process for preparation of protein or peptide
KR102607655B1 (ko) 2017-05-19 2023-11-28 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 리폴딩된 재조합 인간화 라니비주맙의 제조 방법
ES2965485T3 (es) * 2017-08-23 2024-04-15 Novartis Ag Sistema de expresión de proteínas con múltiples copias génicas
CN113631567B (zh) * 2018-07-06 2025-02-07 瓦克化学股份公司 在发酵方法中释放重组蛋白的细菌菌株
JP7762935B2 (ja) * 2019-01-31 2025-10-31 Spiber株式会社 組換え細胞、発現構築物、及び組換えタンパク質の製造方法
KR20210148288A (ko) * 2019-04-02 2021-12-07 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 생체내 리폴딩된 항체 단편의 클로닝 및 발현
CN114774453B (zh) * 2022-03-14 2023-04-21 湖北大学 一种运动发酵单胞菌基因表达严谨调控系统的构建方法和应用
CN116334118A (zh) * 2023-02-23 2023-06-27 四川大学 一种原核体系中单启动子控制多个颗粒蛋白亚基组装同源等同体在胞内恒定比例表达并共自组装的方法
CN118995554B (zh) * 2024-09-09 2025-07-04 江南大学 一种大肠杆菌整合表达体系及其在酶高效表达中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
JP4309656B2 (ja) 2000-12-14 2009-08-05 ジェネンテック・インコーポレーテッド 原核生物で生成させた抗体とその用途
CA2454731C (en) 2001-08-27 2010-11-02 Genentech, Inc. A system for antibody expression and assembly
DK2046382T3 (en) * 2006-07-10 2016-12-12 Esbatech Alcon Biomed Res Unit scFv Antibodies which passes through the epithelial and / or endothelial layer
RU2413769C1 (ru) * 2009-12-24 2011-03-10 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pET-32a, КОДИРУЮЩАЯ ГЕН ЛИГАНД-СВЯЗЫВАЮЩЕГО ДОМЕНА РЕЦЕПТОРА II ТИПА ТРАНСФОРМИРУЮЩЕГО ФАКТОРА РОСТА-β ЧЕЛОВЕКА (TβRII), ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ СЛИТНОГО БЕЛКА ТИОРЕДОКСИН/TβRII И СПОСОБ РЕНАТУРАЦИИ И ОЧИСТКИ ЦЕЛЕВОГО БЕЛКА TβRII
GB201002730D0 (en) * 2010-02-18 2010-04-07 Uni I Oslo Product
US8853380B2 (en) 2010-06-04 2014-10-07 Lupin Limited Modified SAK gene for the production of recombinant proteins
CA2904146C (en) * 2013-03-08 2023-03-21 Neuclone Biologics Pty Ltd A cell expression system
CA2911087A1 (en) * 2013-04-30 2014-11-06 Harish Shandilya Novel cloning, expression & purification method for the preparation of ranibizumab
TW201534726A (zh) * 2013-07-03 2015-09-16 Halozyme Inc 熱穩定ph20玻尿酸酶變異體及其用途

Similar Documents

Publication Publication Date Title
JP2017520261A5 (enExample)
FI3527070T3 (fi) Humanisoituja kevytketjuhiiriä
MX354923B (es) Inmunocitosinas basadas en un dominio sushi de il-15 y de il-15ra.
CL2009002004A1 (es) Anticuerpo o fragmento del mismo que se une al receptor de interleuquina 4 que comprende una region variable de cadena liviana y pesada; secuencias de acido nucleico que codifica dichas regiones; vector que comprende dicha secuencia; celula huesped; metodo para producir dicho anticuerpo; y uso de dicho anticuerpo para trastornos inmunologicos.
PH12020551907A1 (en) Antagonizing cd73 antibody
NZ734307A (en) Antibodies specific for claudin 6 (cldn6)
EA201791961A1 (ru) Антитела, специфичные к cd47 и pd-l1
FI3390442T3 (fi) Anti-C5-vasta-aineita ja käyttömenetelmiä
CO6761352A2 (es) Anticuerpos neutralizadores anti-ccl20
AR093186A1 (es) Proteinas de union al antigeno cd27l
HRP20200996T1 (hr) Dualni cistronski bakterijski ekspresijski sustav
BR112013002695A2 (pt) camundongos que produzem proteínas de ligação compreendendo domínios vl.
MX2016001555A (es) Modulocinas basadas en dominio sushi de interleucina-15 (il-15) y receptor alfa de interleucina-15 (il-15ra).
PE20091420A1 (es) ANTICUERPOS MONOCLONALES ANTI hGM-CSF
JP2010246549A5 (enExample)
SA112330988B1 (ar) أجسام مضادة تخص trop-2 واستخداماتها
WO2016044436A3 (en) Anti-vasa antibodies, and methods of production and use thereof
JP2017533730A5 (enExample)
MX2017004117A (es) Moleculas de enlace, especialmente anticuerpos, enlazadas a l1cam(cd171).
PH12021550244A1 (en) Anti-btla antibody
MX2019000415A (es) Procedimiento para la produccion de una vacuna de adn para inmunoterapia del cancer.
DK1903115T3 (da) Fremgangsmåde til fermentativ fremstilling af antistoffer
WO2019229064A3 (en) Method for producing albicanol compounds
CL2013003746A1 (es) Anticuerpo que se une a antígeno estromal de médula osea 1 (bst1); acido nucleico que codifica dicho anticuerpo; uso de dicho anticuerpo para tratar cancer.
ZA202104048B (en) Anti-il-17a antibody and use thereof